S. Swain, “2-hour 75 gm OGTT for screening and Rescreening at 32-34 weeks for diagnosing gestational diabetes-evaluation of maternal and neonatal outcomes”, Int J Reprod Contracept Obstet Gynecol, vol. 6, no. 7, pp. 2926–2932, Jun. 2017.